STRATA Skin Sciences, Inc. — Director's Dealing 2018

Sep 10, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STRATA Skin Sciences, Inc. (SSKN)
CIK: 0001051514
Period of Report: 2018-06-15

Reporting Person: Rafaeli Dolev (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-15	SSKN Common Stock	J	5814	$1.09	Acquired	5814	Direct

Footnotes

F1: 6/15/18 reporting person was entitled to receive 5,814 shares of common stock pursuant to a "retained risk" provision in the Subscription Agreement & related stock purchase agreement between the Company & the reporting person dated 5/29/18 ("Subscription Agreement"). Subscription Agreement provided that [Purchasers] would receive [additional] shares of common stock in the event of certain contingent expense events, one of which was determined to have occurred 6/15/18, resulted in the purchasers, including the reporting person, acquired additional shares. The number of shares issuable pursuant to that provision, determined on 6/15/18 pursuant to a formula set forth in the Subscription Agreement, provided that, for purposes of determining the number of shares issuable, the common stock would be valued at $1.09 per share, which was the purchase price of the common stock in the Subscription Agreement.